We are live on ! Find out more
AS

Altshuler Shaham Portfolio holdings

AUM $8.04B
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+29.5%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
AUM
$3.32B
AUM Growth
+$1.18B
Cap. Flow
+$615M
Cap. Flow %
18.49%
Top 10 Hldgs %
78.29%
Holding
632
New
99
Increased
142
Reduced
57
Closed
309

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$375M
2
BABA icon
Alibaba
BABA
+$289M
3
TSM icon
TSMC
TSM
+$200M
4
BLK icon
Blackrock
BLK
+$182M
5
CSCO icon
Cisco
CSCO
+$116M

Sector Composition

Rank Sector Weight
1 Technology 27.64%
2 Financials 23.55%
3 Consumer Discretionary 16%
4 Healthcare 3.24%
5 Industrials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
176
Apple
AAPL
$4.46T
$73K ﹤0.01%
808
-6,176
-88% -$479K
QDEL icon
177
QuidelOrtho
QDEL
$1.03B
$70K ﹤0.01%
313
+141
+82% +$22.1K
CRM icon
178
Salesforce
CRM
$165B
$69K ﹤0.01%
369
+240
+186% +$40.4K
FFIV icon
179
F5
FFIV
$23.6B
$66K ﹤0.01%
476
-5,918
-93% -$797K
BMRN icon
180
BioMarin Pharmaceuticals
BMRN
$13.3B
$64K ﹤0.01%
522
+369
+241% +$36.7K
VEEV icon
181
Veeva Systems
VEEV
$41B
$64K ﹤0.01%
273
+269
+6,725% +$53.3K
PODD icon
182
Insulet
PODD
$10.2B
$63K ﹤0.01%
325
+114
+54% +$21.8K
TNDM icon
183
Tandem Diabetes Care
TNDM
$1.61B
$63K ﹤0.01%
+635
New +$50.7K
ZYXI
184
DELISTED
Zynex
ZYXI
$63K ﹤0.01%
+2,779
New +$46.5K
IDXX icon
185
Idexx Laboratories
IDXX
$44.7B
$60K ﹤0.01%
182
+128
+237% +$37.1K
ABBV icon
186
AbbVie
ABBV
$443B
$59K ﹤0.01%
603
+183
+44% +$16.1K
ACN icon
187
Accenture
ACN
$109B
$59K ﹤0.01%
273
+141
+107% +$26.7K
HALO icon
188
Halozyme
HALO
$11.4B
$57K ﹤0.01%
+2,112
New +$47.6K
NBIX icon
189
Neurocrine Biosciences
NBIX
$15.3B
$57K ﹤0.01%
+467
New +$51.6K
MTD icon
190
Mettler-Toledo International
MTD
$28.7B
$54K ﹤0.01%
67
+48
+253% +$35.7K
SPOT icon
191
Spotify
SPOT
$102B
$53K ﹤0.01%
+204
New +$35K
ADSK icon
192
Autodesk
ADSK
$54.5B
$52K ﹤0.01%
219
+57
+35% +$11.2K
EXEL icon
193
Exelixis
EXEL
$12.5B
$52K ﹤0.01%
2,174
+2,143
+6,913% +$49.7K
LMNX
194
DELISTED
Luminex Corp
LMNX
$52K ﹤0.01%
+1,590
New +$50.3K
UTHR icon
195
United Therapeutics
UTHR
$21.5B
$49K ﹤0.01%
401
+101
+34% +$11.4K
ATRC icon
196
AtriCure
ATRC
$2.21B
$47K ﹤0.01%
1,038
+240
+30% +$10.4K
AVLR
197
DELISTED
Avalara, Inc.
AVLR
$47K ﹤0.01%
355
+307
+640% +$30.2K
IRTC icon
198
iRhythm Holdings
IRTC
$4.06B
$46K ﹤0.01%
+398
New +$43.9K
MSCI icon
199
MSCI
MSCI
$41.8B
$46K ﹤0.01%
138
+40
+41% +$12.9K
DOCU
200
DocuSign
DOCU
$12.2B
$45K ﹤0.01%
264
-18
-6% -$2.27K

Similar funds

Altshuler Shaham's Q2 2020 Portfolio in Review

As of Q2 2020, Altshuler Shaham held 632 positions worth $3.32B, up 55% from $2.15B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Altshuler Shaham deployed $615M of net new capital in Q2 2020, opening 99 new positions and adding to 142 existing holdings. Its largest new stake was KraneShares CSI China Internet ETF: 205,053 shares worth $12.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was State Street Financial Select Sector SPDR ETF, an estimated $327M trimmed.

  • Altshuler Shaham's largest Q2 2020 buy was KraneShares CSI China Internet ETF: 205,053 shares worth $12.7M.
  • Altshuler Shaham added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $375M increase.
  • Altshuler Shaham's biggest Q2 2020 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $327M.
  • Altshuler Shaham fully exited Royal Caribbean in Q2 2020, selling an estimated $866K.
  • Altshuler Shaham's ten largest holdings make up 78% of its $3.32B portfolio in Q2 2020.
  • Altshuler Shaham opened 99 new positions and closed 309 in Q2 2020.
  • Altshuler Shaham's portfolio value rose 55% quarter-over-quarter to $3.32B.

Based on Altshuler Shaham's 13F filing for Q2 2020, filed 13 Aug 2020.